- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and Chief Executive Officer, will present an overview of the Company at the Canaccord Adams 28th Annual Global Growth Conference on Thursday, August 14 at 3:00 p.m. ET. The conference is being held August 12-14, 2008 in Boston, MA.
A live audio webcast of the presentation will be accessible through the Investors section of the Company's website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until August 28, 2008.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.
Ferumoxytol, the Company’s key product candidate, is being developed for use as an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia and as a diagnostic agent for vascular-enhanced magnetic resonance imaging to assess peripheral arterial disease. The Company submitted a New Drug Application (NDA) for marketing approval of ferumoxytol as an intravenous iron replacement therapy in chronic kidney disease patients with the U.S. Food and Drug Administration (FDA) in December 2007. The Company expects FDA action on its NDA in the second half of October 2008.
For more information, please click here
AMAG Pharmaceuticals, Inc.
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
FEI Company: Strong Growth Prospects Remain May 1st, 2015
Arrowhead to Present at Upcoming Conferences April 28th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
New Nanodrug Produced in Iran from Milk Thistle May 4th, 2015
No Hogwarts invitation required: Invisibility cloaks move into the real-life classroom: A new solid-state device can demonstrate the physical principles of invisibility cloaks without special equipment or magic spells April 30th, 2015